TORONTO (PRWEB)
March 22, 2022

The outcome of clinical trials is often determined by the quality of the data collected; however, the statistical analysis strategy can be crucial for success. By considering the value of data available at each stage of a cognitive study, the potential for detecting an efficacy signal can be increased.

In this webinar, we explore how a targeted consideration of statistical analysis can drive efficiencies throughout your study, from screening strategies to identify and recruit a homogeneous target population, to patient stratification to improve the signal to noise ratio.

Join this webinar to learn how to integrate statistical planning into a cognitive study design. Participants will learn about patient screening and stratification, and when they will get the most benefit from it. The featured speaker will discuss how a successful statistical strategy supported a clinical study.

Join Elizabeth Baker, PhD, Director of Statistical Sciences, Cambridge Cognitionfor the live webinar Thursday, April 7, 2022 at 10:30 a.m. EDT (3:30 p.m. BST/UK).

For more information or to register for this event, visit Successful statistical strategies for patient screening and stratification.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars for the global life sciences, food and medical device community. Every year, thousands of industry professionals (from life sciences, food and medical devices, private and academic research institutes, healthcare centers, etc.) turn to Xtalks to access to quality content. Xtalks helps life science professionals stay abreast of industry developments, trends and regulations. Xtalks webinars also provide insights on key issues from key industry thought leaders and service providers.

To learn more about Xtalks, visit http://xtalks.com

For more information on hosting a webinar, visit http://xtalks.com/why-host-a-webinar/

Share the article on social networks or by e-mail: